Steward Partners Investment Advisory, LLC

Position in QNCX — Quince Therapeutics, Inc.

CIK 1723397 STAMFORD, CT

Position in QNCX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$18

-$2,202 QoQ

Shares Held

-80.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 25 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Steward Partners Investment Advisory, LLC holds $58,578,486 across 161 Biotechnology names. QNCX ranks #154 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	351,178	$13,699,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	20,851	$10,357,317
3	ARGX	Argenx SE	9,982	$9,261,000
4	REGN	Regeneron Pharmaceuticals, Inc.	5,148	$3,209,983
5	BMRN	Biomarin Pharmaceutical Inc	55,012	$3,147,786
6	CRMD	CorMedix Inc.	232,615	$1,826,027
7	OCUL	Ocular Therapeutix, Inc	165,142	$1,621,694
8	NKTR	Nektar Therapeutics	18,279	$1,276,056

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18	1	-99.9%	Shares	Sole	2026-08-13
2022-06-30	$2,220	1,000	-16.7%	Shares	Sole	2022-08-04
2022-03-31	$7,428	1,200	+140.0%	Shares	Sole	2022-05-02
2021-12-31	$6,310	500	0.0%	Shares	Sole	2022-02-08
2021-09-30	$45,830	500	0.0%	Shares	Sole	2021-11-12
2021-06-30	$26,500	500	0.0%	Shares	Sole	2021-08-13
2021-03-31	$18,015	500	0.0%	Shares	Sole	2021-05-14
2020-12-31	$13,890	500	+117.4%	Shares	Sole	2021-02-11
2020-09-30	$11,500	230	-51.1%	Shares	Sole	2020-10-30
2020-06-30	$21,761	470	—	Shares	Sole	2020-08-06
No filing history on record for this holder in this stock.